HIV Vaccination and Immunotherapy JP
Country:
Japan
Docket No:
436313-000410
Publication Number:
7153332
Patent Expiry:
01/11/2037
Claims Scope:
Patent issued October 5, 2022.
Composition and methods for producing HIV-resistant cells and inhibiting HIV infection in HIV negative individuals; reciting 90% identity to SEQ ID NO: 31 (Vif, Tat, and CCR5); or 90% identity to SEQ ID NO: 2 (Vif guide plus backbone) and SEQ ID NO: 108 (Tat guide plus backbone).